SBI Symposium Collection Advanced Breast Imaging

Advanced breast imaging cases, including MRI and CEM case-based challenges, are encountered in clinical practice. Lack of education in advanced breast imaging may result in the delayed diagnosis of breast cancer. This collection features presentations from the 2025 SBI Breast Imaging Symposium.

Advanced Breast Imaging Lectures

1. BI-RADS MRI

Speakers:  

• Lilian C. Wang, MD

2. Advanced MRI Protocols You Can Use

Speakers: 

• Katja Pinker, MD, FSBI 

• Yiming Gao, MD, FSBI

3. Case Based Challenges: MRI Screening and Extent of Disease

Speakers: 

• Eric L. Rosen, MD, FSBI 

• Roberta M. Strigel MD, FSBI 

4. CEM Implementation and Interpretation  

Speakers: 

• Bhavika Patel, MD, FSBI
• Janice Sung, MD, FSBI  

5. Practical and Pro Tips for Incorporating AI into your Practice 

Speakers 

• Rachel F. Brem, MD, FSBI 

Learning Objectives:

• Describe anticipated changes in the Breast MRI section of the 6th edition of BI-RADS.
• Understand the most appropriate BI-RADS assessment category and management recommendations for a variety of MRI case scenarios.
• Recognize the current clinical indications of fast and abbreviated breast MRI.
• Interpret CEM studies with an emphasis on technical and pathological considerations to enhance diagnostic accuracy.
• Discover how to integrate AI into your breast clinical practice

CME Released: 08/11/2025   CME Expires:  08/10/2028 

Joint Accreditation Statement - In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163

Physicians - Amedco LLC designates this material for a maximum of 3.50 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learner Notification:

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Physicians - Amedco LLC designates this material for a maximum of 3.50 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed below.